Prevention of Maternal Hypothermia After Scheduled Caesarean Section Using Active Intravenous Warming (CESAR-RESOL2)
Postoperative Hypothermia
About this trial
This is an interventional prevention trial for Postoperative Hypothermia focused on measuring Postoperative hypothermia, caesarean section, IV fluids warming
Eligibility Criteria
Inclusion Criteria:
Pregnant women
- without any major co-morbidity (ASA status 1 or 2),
- with normal singleton pregnancy,
- who will deliver by scheduled caesarean section under spinal anesthesia at gestational age ≥ 37 weeks of amenorrhea,
- Aged ≥ 18 years
- with health insurance
Exclusion Criteria:
- Patient refusal to participate in the study
- Maternal temperature ≥38.0 ° C or <36.0 ° C at the time of randomization,
- Spinal anaesthesia refused or contraindicated,
- unplanned caesarean section
- caesarean delivery scheduled since less than 48 hours
- caesarean section performed under epidural or general anesthesia
- participation of the mother in another interventional research or intervention, or during the exclusion period following a previous search
- unability to give written consent
- body mass index> 40kg / m2
- gravidic hypertensive disease
- uncontrolled diabetes
- cardiovascular disease under treatment
- coagulation disorder
Sites / Locations
- Cochin Hospital, Port-Royal Maternity
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
The control group
The warming group
Control group according to usual practices: no active warming (no fluid warming). The fluid warmer device will be set up but not activated. The control group will receive IV fluid coload at room temperature through the fluid warmer set to "off". The device is hidden
"IV fluid warming with the enFlow® or Fluido®Compact IV fluid warmer" : Women will receive IV fluid coload warmed to 40°C through the enFlow® or Fluido®Compact device. The box will be also hidden. The fluid warmer will be turned off at the end of surgery, just before transfer to the PACU.